STONKWHISPER
← Back to Intel
Insider ActivityMLYS

Rodman David Malcom, Chief Medical Officer at Mineralys Therapeutics, Inc., sold $235K of MLYS

Updated Jun 19, 2026
Rodman David Malcom Chief Medical Officer
Mineralys Therapeutics, Inc. · $MLYS
$235K Total Value
9,890 Shares Traded
$23.8106 Price / Share
57,095 Shares Owned After
2026-06-17 Filing Date

Transaction Details

InsiderRodman David Malcom
TitleChief Medical Officer
CompanyMineralys Therapeutics, Inc.
TickerMLYS
Transaction TypeSale
Transaction Date2026-06-15
Shares Traded9,890
Price Per Share$23.8106
Total Value$235K
Filed Date2026-06-17
Accession Number0001933414-26-000094

Ownership Context

Shares Owned After Transaction57,095
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001933414-26-000094

Other Insider Trades — MLYS

Other Trades by Rodman David Malcom

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MLYS — Mineralys Therapeutics, Inc. →

Track MLYS insider activity in real time on The Wire →

Get alerts when Rodman David Malcom files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:01 UTC

Want real-time data? Access The Wire for live sentiment tracking.